These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms. Huang R; Li CH; Cao-Milán R; He LD; Makabenta JM; Zhang X; Yu E; Rotello VM J Am Chem Soc; 2020 Jun; 142(24):10723-10729. PubMed ID: 32464057 [TBL] [Abstract][Full Text] [Related]
4. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts. Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745 [TBL] [Abstract][Full Text] [Related]
5. All-natural gelatin-based bioorthogonal catalysts for efficient eradication of bacterial biofilms. Nabawy A; Huang R; Luther DC; Zhang X; Li CH; Makabenta JM; Rotello VM Chem Sci; 2022 Oct; 13(41):12071-12077. PubMed ID: 36349111 [TBL] [Abstract][Full Text] [Related]
6. Nanomaterial-based bioorthogonal nanozymes for biological applications. Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131 [TBL] [Abstract][Full Text] [Related]
7. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications. Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795 [TBL] [Abstract][Full Text] [Related]
8. In situ activation of therapeutics through bioorthogonal catalysis. Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074 [TBL] [Abstract][Full Text] [Related]
9. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts. Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics. Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065 [TBL] [Abstract][Full Text] [Related]
11. Bioorthogonal nanozymes: an emerging strategy for disease therapy. Zhang Z; Fan K Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377 [TBL] [Abstract][Full Text] [Related]
12. Bioorthogonal nanozymes for breast cancer imaging and therapy. Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections. Gupta A; Das R; Makabenta JM; Gupta A; Zhang X; Jeon T; Huang R; Liu Y; Gopalakrishnan S; Milán RC; Rotello VM Mater Horiz; 2021 Nov; 8(12):3424-3431. PubMed ID: 34700339 [TBL] [Abstract][Full Text] [Related]
14. Enhanced Efficiency of Pd(0)-Based Single Chain Polymeric Nanoparticles for Deng L; Sathyan A; Adam C; Unciti-Broceta A; Sebastian V; Palmans ARA Nano Lett; 2024 Feb; 24(7):2242-2249. PubMed ID: 38346395 [TBL] [Abstract][Full Text] [Related]
15. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics. Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910 [TBL] [Abstract][Full Text] [Related]
16. Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts. Tonga GY; Jeong Y; Duncan B; Mizuhara T; Mout R; Das R; Kim ST; Yeh YC; Yan B; Hou S; Rotello VM Nat Chem; 2015 Jul; 7(7):597-603. PubMed ID: 26100809 [TBL] [Abstract][Full Text] [Related]
17. Protection and Isolation of Bioorthogonal Metal Catalysts by Using Monolayer-Coated Nanozymes. Zhang X; Fedeli S; Gopalakrishnan S; Huang R; Gupta A; Luther DC; Rotello VM Chembiochem; 2020 Oct; 21(19):2759-2763. PubMed ID: 32400081 [TBL] [Abstract][Full Text] [Related]
18. Control of Intra- versus Extracellular Bioorthogonal Catalysis Using Surface-Engineered Nanozymes. Das R; Landis RF; Tonga GY; Cao-Milán R; Luther DC; Rotello VM ACS Nano; 2019 Jan; 13(1):229-235. PubMed ID: 30516966 [TBL] [Abstract][Full Text] [Related]
19. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells. Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329 [TBL] [Abstract][Full Text] [Related]
20. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics. Gu L; Faig A; Abdelhamid D; Uhrich K Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]